Suchergebnisse - "de Sousa, Eric"

PubPharm (7)

1

RBD- specific Th1 responses are associated with vaccine-induced protection against SARS-CoV-2 infection in patients with hematological malignancies

enthalten in: Oncoimmunology | 2023

von Bigenwald, C. | Haddad, Y. | Thelemaque, C. | +17

2

The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals

enthalten in: Cancer discovery | 2022

von Fahrner, J. | Lahmar, I. | Goubet, A. | +65

CommentIn: Cancer Discov. 2022 Apr 1;12(4):892-894. - PMID 35373282

3

Targeting Neoepitopes to Treat Solid Malignancies : Immunosurgery

enthalten in: Frontiers in immunology | 2021

von de Sousa, E. | Lérias, J. | Beltran, A. | +11

4

Mortality in COVID-19 disease patients : Correlating the association of major histocompatibility complex (MHC) with severe acute respiratory syndrome 2 (SARS-CoV-2) variants

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2020

von de Sousa, E. | Ligeiro, D. | Lérias, J. | +9

5

Clinically Relevant Immune Responses against Cytomegalovirus : Implications for Precision Medicine

enthalten in: International journal of molecular sciences | 2019

von Lérias, J. | Paraschoudi, G. | Silva, I. | +9

6

Trained Immunity for Personalized Cancer Immunotherapy : Current Knowledge and Future Opportunities

enthalten in: Frontiers in microbiology | 2019

von Lérias, J. | de Sousa, E. | Paraschoudi, G. | +12

7

Microbes as Master Immunomodulators : Immunopathology, Cancer and Personalized Immunotherapies

enthalten in: Frontiers in cell and developmental biology | 2019

von Lérias, J. | Paraschoudi, G. | de Sousa, E. | +11

1
[1]